Tate & Lyle Overview
- Year Founded
-
1858
- Status
-
Public
- Employees
-
4,875
- Stock Symbol
-
TATE
- Investments
-
22
- Share Price
-
$7.42
- (As of Friday Closing)
Tate & Lyle General Information
Description
Tate & Lyle is a global provider of food and beverage ingredients and solutions. Following the sale of its commodity ingredients business, as well as its exit from the sugar business a decade earlier, Tate & Lyle is now focused on specialty ingredients-sweeteners, starches, specialty gums, and soluble fiber. It has nearly 5,000 employees and operates in over 120 countries, with most of its revenue generated in North America.
Contact Information
Website
www.tateandlyle.comCorporate Office
- 5 Marble Arch
- London W1H 7EJ
- England, United Kingdom
Corporate Office
- 5 Marble Arch
- London W1H 7EJ
- England, United Kingdom
Tate & Lyle Stock Performance
As of 13-Nov-2026, Tate & Lyle’s stock price is $7.42. Its current market cap is $3.28B with 443M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.42 | $7.45 | $4.26 - $7.85 | $3.28B | 443M | 1.7M | $0.21 |
Tate & Lyle Financials Summary
As of 30-Sep-2026, Tate & Lyle has a trailing 12-month revenue of $2.71B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 4,529,735 | 3,374,426 | 2,895,754 | 3,444,614 |
| Revenue | 2,709,696 | 2,688,071 | 2,213,919 | 2,069,433 |
| EBITDA | 374,075 | 471,685 | 298,420 | 378,202 |
| Net Income | 92,513 | 129,982 | 182,368 | 236,219 |
| Total Assets | 4,818,225 | 4,828,704 | 4,815,193 | 2,881,022 |
| Total Debt | 1,756,893 | 1,704,403 | 1,689,587 | 744,874 |
Tate & Lyle Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tate & Lyle Comparisons
Industry
Financing
Details
Tate & Lyle Competitors (51)
One of Tate & Lyle’s 51 competitors is Glanbia, a Corporation company based in Kilkenny, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glanbia | Corporation | Kilkenny, Ireland | ||||
| Ingredion | Corporation | Westchester, IL | ||||
| Danone | Corporation | Paris, France | ||||
| Pepsico | Corporation | Purchase, NY | ||||
| The Campbell's | Corporation | Camden, NJ |
Tate & Lyle Patents
Tate & Lyle Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025083419-A1 | Allulose or erythritol for use in improving gut microbiota population and medical treatment | Inactive | 20-Oct-2023 | ||
| WO-2024121721-A1 | Methods for obtaining steviol glycosides | Inactive | 05-Dec-2022 | ||
| GB-202216364-D0 | Sweetener composition, method for reducing browning, and food product | Inactive | 03-Nov-2022 | ||
| WO-2023214185-A1 | Low sugar, high fiber chewable sweets | Inactive | 06-May-2022 | ||
| GB-202204932-D0 | Sweetener composition, method for reducing browning, and food product | Inactive | 04-Apr-2022 |
Tate & Lyle Signals
Tate & Lyle Investments & Acquisitions (22)
Tate & Lyle’s most recent deal was a Merger/Acquisition with CP Kelco for . The deal was made on 15-Nov-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CP Kelco | 15-Nov-2024 | Merger/Acquisition | Specialty Chemicals | ||
| Quantum Hi-Tech (China) Biological Co. | 09-Jun-2022 | Merger/Acquisition | Food Products | ||
| Quantum High-Tech | 09-Jun-2022 | Merger/Acquisition | Food Products | ||
| Artesa | 03-May-2022 | Merger/Acquisition | Food Products | ||
| Chaodee Modified Starch | 10-Feb-2021 | Merger/Acquisition | Food Products |
Tate & Lyle ESG
Risk Overview
Risk Rating
Updated November, 08, 2026
27.06 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Food Products
Industry
of 508
Rank
Percentile
Packaged Foods
Subindustry
of 298
Rank
Percentile
Tate & Lyle Exits (3)
Tate & Lyle’s most recent exit was on 01-Apr-2007 from Eridania Italia. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Eridania Italia | 01-Apr-2007 | Completed |
|
||
| Primient Covation | 01-Jan-2004 | Completed |
|
||
| Tate & Lyle (Arla Factory in Kimstad) | Corporate Asset Purchase | Completed |
Tate & Lyle Affiliates
Subsidiaries (15)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Quantum High-Tech | Jiangmen, China | 2020 | |
| Tate & Lyle (Oat Ingredients Business) | Kimstad, Sweden | 2013 | |
| Tate & Lyle Global Shared Services | Łodź, Poland | 2010 | |
| Tate & Lyle Services ( Belgium) | Aalst, Belgium | 2007 | |
| Tate & Lyle Ingredients France | Levallois-Perret, France | 2007 |
Tate & Lyle FAQs
-
When was Tate & Lyle founded?
Tate & Lyle was founded in 1858.
-
Where is Tate & Lyle headquartered?
Tate & Lyle is headquartered in London, United Kingdom.
-
What is the size of Tate & Lyle?
Tate & Lyle has 4,875 total employees.
-
What industry is Tate & Lyle in?
Tate & Lyle’s primary industry is Food Products.
-
Is Tate & Lyle a private or public company?
Tate & Lyle is a Public company.
-
What is Tate & Lyle’s stock symbol?
The ticker symbol for Tate & Lyle is TATE.
-
What is the current stock price of Tate & Lyle?
As of 13-Nov-2026 the stock price of Tate & Lyle is $7.42.
-
What is the current market cap of Tate & Lyle?
The current market capitalization of Tate & Lyle is $3.28B.
-
What is Tate & Lyle’s current revenue?
The trailing twelve month revenue for Tate & Lyle is $2.71B.
-
Who are Tate & Lyle’s competitors?
Glanbia, Ingredion, Danone, Pepsico, and The Campbell's are some of the 51 competitors of Tate & Lyle.
-
What is Tate & Lyle’s annual earnings per share (EPS)?
Tate & Lyle’s EPS for 12 months was $0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process